Togashi Y - Search Results

1

The OCT4 pseudogene POU5F1B is amplified and promotes an aggressive phenotype in gastric cancer.

Hayashi H, Arao T, Togashi Y, Kato H, Fujita Y, De Velasco MA, Kimura H, Matsumoto K, Tanaka K, Okamoto I, Ito A, Yamada Y, Nakagawa K, Nishio K. Hayashi H, et al. Among authors: togashi y. Oncogene. 2015 Jan 8;34(2):199-208. doi: 10.1038/onc.2013.547. Epub 2013 Dec 23. Oncogene. 2015. PMID: 24362523

2

Melanoma transition is frequently accompanied by a loss of cytoglobin expression in melanocytes: a novel expression site of cytoglobin.

Fujita Y, Koinuma S, De Velasco MA, Bolz J, Togashi Y, Terashima M, Hayashi H, Matsuo T, Nishio K. Fujita Y, et al. Among authors: togashi y. PLoS One. 2014 Apr 10;9(4):e94772. doi: 10.1371/journal.pone.0094772. eCollection 2014. PLoS One. 2014. PMID: 24722418 Free PMC article.

3

Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma.

Hayashi H, Arao T, Matsumoto K, Kimura H, Togashi Y, Hirashima Y, Horita Y, Iwasa S, Okita NT, Honma Y, Takashima A, Kato K, Hamaguchi T, Shimada Y, Nakagawa K, Nishio K, Yamada Y. Hayashi H, et al. Among authors: togashi y. Oncotarget. 2014 May 15;5(9):2588-95. doi: 10.18632/oncotarget.1811. Oncotarget. 2014. PMID: 24809949 Free PMC article.

4

Homozygous deletion of the activin A receptor, type IB gene is associated with an aggressive cancer phenotype in pancreatic cancer.

Togashi Y, Sakamoto H, Hayashi H, Terashima M, de Velasco MA, Fujita Y, Kodera Y, Sakai K, Tomida S, Kitano M, Ito A, Kudo M, Nishio K. Togashi Y, et al. Mol Cancer. 2014 May 27;13:126. doi: 10.1186/1476-4598-13-126. Mol Cancer. 2014. PMID: 24886203 Free PMC article.

5

Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production.

Togashi Y, Arao T, Kato H, Matsumoto K, Terashima M, Hayashi H, de Velasco MA, Fujita Y, Kimura H, Yasuda T, Shiozaki H, Nishio K. Togashi Y, et al. Oncotarget. 2014 May 30;5(10):2962-73. doi: 10.18632/oncotarget.1561. Oncotarget. 2014. PMID: 24930674 Free PMC article.

6

KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival.

Terashima M, Fujita Y, Togashi Y, Sakai K, De Velasco MA, Tomida S, Nishio K. Terashima M, et al. Among authors: togashi y. Oncotarget. 2014 Aug 30;5(16):7040-50. doi: 10.18632/oncotarget.2220. Oncotarget. 2014. PMID: 25051373 Free PMC article.

7

Hypoxia induces resistance to ALK inhibitors in the H3122 non-small cell lung cancer cell line with an ALK rearrangement via epithelial-mesenchymal transition.

Kogita A, Togashi Y, Hayashi H, Sogabe S, Terashima M, De Velasco MA, Sakai K, Fujita Y, Tomida S, Takeyama Y, Okuno K, Nakagawa K, Nishio K. Kogita A, et al. Among authors: togashi y. Int J Oncol. 2014 Oct;45(4):1430-6. doi: 10.3892/ijo.2014.2574. Epub 2014 Aug 1. Int J Oncol. 2014. PMID: 25096400 Free PMC article.

8

Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidence.

Togashi Y, Hayashi H, Nakagawa K, Nishio K. Togashi Y, et al. Drug Des Devel Ther. 2014 Jul 31;8:1037-46. doi: 10.2147/DDDT.S50358. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25114510 Free PMC article. Review.

9

Synergistic antitumor effects of S-1 with eribulin in vitro and in vivo for triple-negative breast cancer cell lines.

Terashima M, Sakai K, Togashi Y, Hayashi H, De Velasco MA, Tsurutani J, Nishio K. Terashima M, et al. Among authors: togashi y. Springerplus. 2014 Aug 8;3:417. doi: 10.1186/2193-1801-3-417. eCollection 2014. Springerplus. 2014. PMID: 25140293 Free PMC article.

10

MEK inhibitor for gastric cancer with MEK1 gene mutations.

Sogabe S, Togashi Y, Kato H, Kogita A, Mizukami T, Sakamoto Y, Banno E, Terashima M, Hayashi H, de Velasco MA, Sakai K, Fujita Y, Tomida S, Yasuda T, Takeyama Y, Okuno K, Nishio K. Sogabe S, et al. Among authors: togashi y. Mol Cancer Ther. 2014 Dec;13(12):3098-106. doi: 10.1158/1535-7163.MCT-14-0429. Epub 2014 Sep 24. Mol Cancer Ther. 2014. PMID: 25253779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters